Methods of managing the symptoms of premenstrual syndrome

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The The Procter & Gamble Company patent solves the following problem:

Serotonin is a neurotransmitter most responsible for emotional responses, and believed by the inventor, to play a key role in the transmission of pain signals from the source of pain to the brain. Thus, the conditions such as PMS, perimenopause, menopause / post-menopause, seasonal affective disorder, stress, and depression may be increased when the brain experiences a serotonin deficiency. Tryptophan is a precursor to serotonin, and it competes with other large neutral amino acids (LNAA) for transport to the brain. Therefore, some tried to increase brain serotonin by raising the ratio of tryptophan to LNAA in the blood by various mechanisms.

Our analysis of this patent is as follows:

The Procter & Gamble Company’s patent US 7064104 B2 deals with Methods of managing the symptoms of premenstrual syndrome.
Methods of increasing the tryptophan: LNAA ratio in blood of a man appointed. Such methods are useful in managing conditions such as premenstrual syndrome, perimenopause, menopause, seasonal affective disorder, stress, or depression. The method includes orally administering specific doses of a carbohydrate blend with high tryptophan containing proteins.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Full-length human cDNAs encoding potentially secreted proteins

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Serono Genetics Institute, S.A. patent solves the following problem:

The estimated 50,000-100,000 genes scattered along the human chromosome to offer great promise for understanding, diagnosis, and treatment of human diseases. In addition, probes capable of specifically hybridizing to loci distributed throughout the human genome find applications in the construction of high resolution chromosome maps and to identify the man.

Our analysis of this patent is as follows:

Serono Genetics Institute, S.A.’s patent US 7060479 B2 deals with Full-length human cDNAs encoding potentially secreted proteins.
genset invention related polynucleotides and polypeptides. The genset products can be used as reagents in forensic analyzes, as chromosome markers, as tissue / cell / organelle-specific markers, the expression vector production. Moreover, they are used in screening and diagnostic assays for abnormal genset expression and / or biological activity and for screening compounds that can be used to treat genset-related diseases.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.